Apoptosis and mitochondrial dysfunction in human chondrocytes following exposure to lidocaine, bupivacaine, and ropivacaine

Journal of Bone and Joint Surgery

Volumn 92, Issue 3, 2010, Pages 609-618

  Grishko, Valentina ^a   Xu, Min ^a   Wilson, Glenn ^a   Pearsall IV, Albert W ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BUPIVACAINE; LIDOCAINE; MITOCHONDRIAL PROTEIN; PROCASPASE 3; PROCASPASE 9; ROPIVACAINE; AMIDE; LOCAL ANESTHETIC AGENT;

APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; HUMAN; HUMAN CELL; KNEE ARTHROPLASTY; OSTEOARTHRITIS; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; ARTICULAR CARTILAGE; DRUG EFFECT; ENZYMOLOGY; FEMALE; FLOW CYTOMETRY; MALE; MIDDLE AGED; MITOCHONDRION; WESTERN BLOTTING;

AMIDES; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; APOPTOSIS; BLOTTING, WESTERN; BUPIVACAINE; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; MITOCHONDRIA;

EID: 77950871584     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.H.01847     Document Type: Article

References (44)

1. Nair GS, Abrishami A, Lermitte J, Chung F. Systematic review of spinal anaesthesia using bupivacaine for ambulatory knee arthroscopy. Br J Anaesth. 2009;102:307-15.
2. Chu CR, Izzo NJ, Papas NE, Fu FH. In vitro exposure to 0.5% bupivacaine is cytotoxic to bovine articular chondrocytes. Arthroscopy. 2006;22:693-9.
3. Gomoll AH, Kang RW, Williams JM, Bach BR, Cole BJ. Chondrolysis after continuous intra-articular bupivacaine infusion: an experimental model investigating chondrotoxicity in the rabbit shoulder. Arthroscopy. 2006;22:813-9.
4. Piper SL, Kim HT. Comparison of ropivacaine and bupivacaine toxicity in human articular chondrocytes. J Bone Joint Surg Am. 2008;90:986-91.
5. Dragoo JL, Korotkova T, Kanwar R, Wood B. The effect of local anesthetics via pain pump on chondrocyte viability. Am J Sports Med. 2008;36:1484-8. (Pubitemid 352019488)
6. Karpie JC, Chu CR. Lidocaine exhibits dose- and time-dependent cytotoxic effects on bovine articular chondrocytes in vitro. Am J Sports Med. 2007;35:1621-7.
7. Kim M, Lee YS, Mathews HL, Wurster RD. Induction of apoptotic cell death in a neuroblastoma cell line by dibucaine. Exp Cell Res. 1997;231:235-41. (Pubitemid 27187974)
8. Johnson ME, Uhl CB, Spittler KH, Wang H, Gores GJ. Mitochondrial injury and caspase activation by the local anesthetic lidocaine. Anesthesiology. 2004;101:1184-94. (Pubitemid 39430799)
9. Friederich P, Schmitz TP. Lidocaine-induced cell death in a human model of neuronal apoptosis. Eur J Anaesthesiol. 2002;19:564-70. (Pubitemid 34855559)
10. Kamiya Y, Ohta K, Kaneko Y. Lidocaine-induced apoptosis and necrosis in U937 cells depending on its dosage. Biomed Res. 2005;26:231-9.
11. Karniel M, Beitner R. Local anesthetics induce a decrease in the levels of glucose 1, 6-bisphosphate, fructose 1,6-bisphosphate, and ATP, and in the viability of melanoma cells. Mol Genet Metab. 2000;69:40-5.
12. Hille B. Ion channels of excitable membranes. 3rd ed. Sunderland, MA: Sinauer; 2001. Classic mechanisms of block. p 503-37.
13. Urban BW, Friederich P. Local anesthetics toxicity. In: Schulte am Esch J, Scholz J, Tonner PH, editors. Molecular pharmacology of anaesthesia. Lengerich, Germany: Pabst; 2000. p 151-63.
14. Punke MA, Licher T, Pongs O, Friederich P. Inhibition of human TREK-1 channels by bupivacaine. Anesth Analg. 2003;96:1665-73.
15. Scholz A. Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. Br J Anaesth. 2002;89:52-61.
16. Olschewski A, Olschewski H, Bräu ME, Hempelmann G, Vogel W, Safronov BV. Effect of bupivacaine on ATP-dependent potassium channels in rat cardiomyocytes. Br J Anaesth. 1999;82:435-8.
17. Dabadie P, Bendriss P, Erny P, Mazat JP. Uncoupling effects of local anesthetics on rat liver mitochondria. FEBS Lett. 1987;226:77-82.
18. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol. 1998;60:619-42.
19. Irwin W, Fontaine E, Agnolucci L, Penzo D, Betto R, Bortolotto S, Reggiani C, Salviati G, Bernardi P. Bupivacaine myotoxicity is mediated by mitochondria. J Biol Chem. 2002;277:12221-7.
20. Wei YH, Lu CY, Lee HC, Pang CY, Ma YS. Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function. Ann N Y Acad Sci. 1998;854:155-70.
21. de Grey AD. Reactive oxygen species production in the mitochondrial matrix: implications for the mechanism of mitochondrial mutation accumulation. Rejuvenation Res. 2005;8:13-7.
22. Wei YH, Lee HC. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med (Maywood). 2002;227:671-82.
23. Mandavilli BS, Santos JH, Van Houten B. Mitochondrial DNA repair and aging. Mutat Res. 2002;509:127-51.
24. Lee CH, Ruben PC. Interaction between voltage-gated channels and the neurotoxin, tetrodotoxin. Channels (Austin). 2008;2:407-12.
25. Silos-Santiago I. The role of tetrodotoxin-resistant sodium channels in pain states: are they the next target for analgesic drugs? Curr Opin Investig Drugs. 2008;9:83-9.
26. Tanahashi S, Iida H, Oda A, Osawa Y, Uchida M, Dohi S. Effects of ifenprodil on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons. Eur J Anaesthesiol. 2007;24:782-8. (Pubitemid 47237687)
27. Bedner E, Li X, Gorczyca W, Melamed MR, Darzynkiewicz Z. Analysis of apoptosis by laser scanning cytometry. Cytometry. 1999;35:181-95. (Pubitemid 29104396)
28. Grishko V, Xu M, Ho R, Mates A, Watson S, Kim JT, Wilson GL, Pearsall AW 4th. Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes. J Biol Chem. 2009;284:9132-9.
29. Farmer C, Smith K, Docherty R. Low concentrations of tetrodotoxin interact with tetrodotoxin-resistant voltage-gated sodium channels. Br J Pharmacol. 2008;155: 34-43.
30. Blair NT, Bean BP. Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J Neurosci. 2002;22:10277-90.
31. Diaz D, Delgadillo DM, Hernández-Gallegos E, Ramírez- Domínguez ME, Hinojosa LM, Ortiz CS, Berumen J, Camacho J, Gomora JC. Functional expression of voltage-gated sodium channels in primary cultures of human cervical cancer. J Cell Physiol. 2007;210:469-78.
32. Sandhiya S, Dkhar SA. Potassium channels in health, disease & development of channel modulators. Indian J Med Res. 2009;129:223-32.
33. Grishko VI, Ho R, Wilson GL, Pearsall AW 4th. Diminished mitochondrial DNA integrity and repair capacity in OA chondrocytes. Osteoarthritis Cartilage. 2009;17: 107-13.
34. Santos JH, Hunakova L, Chen Y, Bortner C, Van Houten B. Cell sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death. J Biol Chem. 2003;278:1728-34.
35. Ballinger SW, Patterson C, Yan CN, Doan R, Burow DL, Young CG, Yakes FM, Van Houten B, Ballinger CA, Freeman BA, Runge MS. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res. 2000;86:960-6.
36. Esteve JM, Mompo J, Garcia de la Asuncion J, Sastre J, Asensi M, Boix J, Vina JR, Vina J, Pallardo FV. Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis: studies in vivo and in vitro. FASEB J. 1999;13:1055-64. (Pubitemid 29249731)
37. Hollensworth SB, Shen C, Sim JE, Spitz DR, Wilson GL, LeDoux SP. Glial cell type-specific responses to menadione-induced oxidative stress. Free Radic Biol Med. 2000;28:1161-74. (Pubitemid 30417458)
38. Dobson AW, Kelley MR, Wilson GL, LeDoux SP. Targeting DNA repair proteins to mitochondria. Methods Mol Biol. 2002;197:351-62.
39. Rachek LI, Grishko VI, Alexeyev MF, Pastukh VV, LeDoux SP, Wilson GL. Endonuclease III and endonuclease VIII conditionally targeted into mitochondria enhance mitochondrial DNA repair and cell survival following oxidative stress. Nucleic Acids Res. 2004;32:3240-7.
40. Wohlrab D, Vocke M, Klapperstück T, Hein W. Effects of potassium and anion channel blockers on the cellular response of human osteoarthritic chondrocytes. J Orthop Sci. 2004;9:364-71. (Pubitemid 39108456)
41. Kawano T, Oshita S, Takahashi A, Tsutsumi Y, Tomiyama Y, Kitahata H, Kuroda Y, Nakaya Y. Molecular mechanisms of the inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on sarcolemmal ATP-sensitive potassium channels in the cardiovascular system. Anesthesiology. 2004;101:390-8.
42. Holmuhamedov EL, Jahangir A, Oberlin A, Komarov A, Colombini M, Terzic A. Potassium channel openers are uncoupling protonophores: implication in cardioprotection. FEBS Lett. 2004;568:167-70.
43. Katoh H, Nishigaki N, Hayashi H. Diazoxide opens the mitochondrial permeability transition pore and alters Ca2+ transients in rat ventricular myocytes. Circulation. 2002;105:2666-71.
44. Sun Z, Zhang X, Ito K, Li Y, Montgomery RA, Tachibana S, Williams GM. Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide. Am J Physiol Renal Physiol. 2008;294:F491-8.